{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:29:38Z","timestamp":1783024178354,"version":"3.54.6"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1097\/rlu.0000000000006549","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:00:46Z","timestamp":1780923646000},"page":"756-757","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evidence Synthesis in Prostate Cancer Screening and Imaging-Based Risk Stratification"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4952-6305","authenticated-orcid":false,"given":"Takeshi","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/RLU.0000000000006309","article-title":"The PRIMARY scoring system on PSMA PET for clinically significant prostate cancer detection: a systematic review and meta-analysis","volume":"51","author":"Mourato","year":"2026","journal-title":"Clin Nucl Med"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"r1179","DOI":"10.1136\/bmj.r1179","article-title":"Prostate cancer: polygenic risk scores have not shown clinical benefit","volume":"389","author":"Lucassen","year":"2025","journal-title":"BMJ"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1245\/s10434-025-18262-0","article-title":"Evidence-based prostate cancer screening","volume":"33","author":"Takahashi","year":"2026","journal-title":"Ann Surg Oncol"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1991","journal-title":"N Engl J Med"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"d6395","DOI":"10.1136\/bmj.d6395","article-title":"Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? Yes","volume":"343","author":"Penston","year":"2011","journal-title":"BMJ"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJMc2517122","article-title":"European study of prostate cancer screening\u201423-year follow-up","volume":"394","author":"Thompson","year":"2026","journal-title":"N Engl J Med"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJMc2517122","article-title":"European study of prostate cancer screening\u201423-year follow-up","volume":"394","author":"Raghavan","year":"2026","journal-title":"N Engl J Med"},{"key":"R10-20260702","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJMoa2503223","article-title":"European study of prostate cancer screening\u201423-year follow-up","volume":"393","author":"Roobol","year":"2025","journal-title":"N Engl J Med"},{"key":"R11-20260702","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJMc2517122","article-title":"European study of prostate cancer screening\u201423-year follow-up","volume":"394","author":"Roobol","year":"2026","journal-title":"Reply N Engl J Med"},{"key":"R12-20260702","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ajog.2015.10.147","article-title":"Cervical cancer screening: evidence behind the guidelines","volume":"214","author":"Lees","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20260702","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/jamainternmed.2017.0340","article-title":"Recent patterns of prostate-specific antigen testing for prostate cancer screening in the United States","volume":"177","author":"Fedewa","year":"2017","journal-title":"JAMA Intern Med"},{"key":"R14-20260702","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:07:35Z","timestamp":1783022855000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006549","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"2026-02-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}